company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3381681.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3381681.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,494.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,178836.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31190.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3233541.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3233541.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-148984.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-148984.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-148984.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-269130.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3154000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-255000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2629870.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2629870.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-752655.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,18171.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3703853.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3703853.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,518.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,155759.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,990725.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2556851.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2556851.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-159931.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-159931.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-159931.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-173870.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4025000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3851130.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3851130.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1134348.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11929.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3702280.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3702280.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,494.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,159337.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,538613.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3003836.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3003836.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,120020.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,120020.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,120020.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-185000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,500000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1800000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2115000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2115000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-768816.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5910.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4556509.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4556509.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,494.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,137221.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,442313.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3976481.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3976481.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,175594.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,175594.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,175594.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-210620.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-500000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3661242.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,415309.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3365931.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3365931.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-434956.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2111.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-582851.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-582851.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,494.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10726.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2129825.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2701456.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2701456.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-48708.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-48708.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-48708.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-265432.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2579222.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2313790.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2313790.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-436374.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1083.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5625360.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5625360.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,518.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,514716.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6439101.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11549227.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11549227.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-113906.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-113906.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-113906.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1486948.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26328536.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-309.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24841279.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24841279.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13178146.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,28896.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7022644.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7022644.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,494.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,438071.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-259262.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6843341.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6843341.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-278202.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-278202.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-278202.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7121543.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:15:56+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10558356.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10558356.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,506.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-160000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,349929.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3396262.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6971659.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6971659.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20116798.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20116798.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20116798.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3358000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,51750000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48392000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48392000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21303543.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9885000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9885000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,37000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,553000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,38000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9256000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9256000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-719000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-719000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-719000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,3358000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3566000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-208000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-208000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10183000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11978000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11978000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,37000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1171000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2716000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8054000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8054000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-650000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-678000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-678000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3774000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4112000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3566000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3904000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3904000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4828000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,31000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,923000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,932000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21124000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21124000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,29953000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,29953000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-77000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2817000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2740000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2740000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11569000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,25000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30555000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30555000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,513000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1535000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,42000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28431000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28431000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-69000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-30000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-30069000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-30069000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12747000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-140000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,200000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5088000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,192201000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,192201000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,133701000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27389000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27389000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2349000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1253000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23149000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23149000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-153000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5558000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5405000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5405000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-67752000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,122000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33668000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33668000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1825000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5389000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,535000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25886000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25886000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-251000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9114000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8863000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8863000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17023000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,102000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25996000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25996000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1534000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2785000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21640000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21640000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-188000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-230000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-230000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2091000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2091000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2091000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19779000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,7416000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30447000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30447000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,60000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,494000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1872000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2293000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30314000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30314000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,49988000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,49988000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,49988000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,404000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-404000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,63000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19737000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5963000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4153000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28827000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-629000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27552000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27552000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-43000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50097000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,50054000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,50054000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22502000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,45000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38556000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38556000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,253000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2708000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2979000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32575000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32575000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-229000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-229000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-229000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,89845000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,89868000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,89868000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57064000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2969000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40243000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40243000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,252000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5019000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2998000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31860000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31860000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-434000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,190000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-244000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-244000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-32129000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59867000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59867000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2263000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18624000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1174000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-37766000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-37766000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,434000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10629000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11063000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11063000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26703000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2970000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,608000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4041000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3538000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-63452000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-63452000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1591000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,121604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,329000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,120342000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,120342000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,56875000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,44000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-73889000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-73889000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,39000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,177000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13299000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3054000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-57320000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-57320000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-57302000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,698000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48871000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48871000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,250000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4785000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15485000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-59280000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-59280000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,95140000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,95140000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,95140000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35827000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-24000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36974000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36974000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,44000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,307000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5194000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1408000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32837000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32837000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-162000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-162000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-162000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,52198000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52198000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52198000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19199000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,698000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,48000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,531000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5410000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5639000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35754000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35754000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2500000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2470000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2470000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-38328000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29691000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29691000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,58000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4170000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12876000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-37735000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-37735000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-89000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-89000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-89000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,399000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,399000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,399000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-37425000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2301000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34543000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34543000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,73000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,635000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3937000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14307000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15591000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15591000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15586000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1635000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1133000.0
